StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Consolidated — Intersegment Revenue Eliminations by Year

Consolidated — Intersegment Revenue Eliminations ($M)

Cvs Health Consolidated — Intersegment Revenue Eliminations: -$71,563M in FY2025, up 26.9% from a year earlier. That is the lowest of the 8 years on record here.

Latest, FY2025
-71,563
Period ended Dec 31, 2025
Change on a year earlier
+26.9%
-56,412 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Total revenues | $ | 143,354 | $ | 190,425 | $ | 139,367 | $ | 484 | $ | (71,563) | $ | 402,067”

Source: CVS Health 8-K (2026-02-10) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated — Intersegment Revenue Eliminations ($M)Year on yearSource
FY2025Dec 31, 2025-71,563+26.9%CVS Health 8-K (2026-02-10) ↗
FY2024Dec 31, 2024-56,412+8.6%CVS Health 8-K (2026-02-10) ↗
FY2023Dec 31, 2023-51,927+9.1%CVS Health 8-K (2025-02-12) ↗
FY2022Dec 31, 2022-47,585+8.3%CVS Health 8-K (2024-02-07) ↗
FY2021Dec 31, 2021-43,923+8.9%CVS Health 8-K (2023-02-08) ↗
FY2020Dec 31, 2020-40,323-2.7%CVS Health 8-K (2022-02-09) ↗
FY2019Dec 31, 2019-41,439+22.9%CVS Health 8-K (2021-02-16) ↗
FY2018Dec 31, 2018-33,714–CVS Health 8-K (2020-02-12) ↗

Cite this data

StockData. (2026). Cvs Health Consolidated — Intersegment Revenue Eliminations ($M), annual FY2018–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/cons-intersegment-elim-rev

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.